A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis-Reference-Cited by-同舟云学术

A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis

Published:1996-03 Issue:3 Volume:24 Page:381-384
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Stuber Frank,Petersen Marc,Bokelmann Frank,Schade Ulrich

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference9 articles.

1. Role of tumor necrosis factor-α in disease states and inflammation

2. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

3. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans

4. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

5. Human Lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization

Cited by 507 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-1 β gene (+3954 C/T, exon 5, rs1143634) and NOS2 (exon 22) polymorphisms associate with early aseptic loosening of arthroplasties;Scientific Reports;2022-11-01

2. Impact of Inherited Genetic Variants on Critically Ill Septic Children;Pathogens;2022-01-14

3. A Functional Variant of CXCL16 Is Associated With Predisposition to Sepsis and MODS in Trauma Patients: Genetic Association Studies;Frontiers in Genetics;2021-09-03

4. The effects of genotype on inflammatory response in hippocampal progenitor cells: A computational approach;Brain, Behavior, & Immunity - Health;2021-08

5. Lymphotoxin-alpha +252A/G Single-Nucleotide Polymorphism in Colorectal Cancer in the Ethnic Kashmiri Population: A Case-Control Study;CLIN CANCER INVESTIG;2021